Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics and Preliminary Efficacy Study of CA-008 in Patients Undergoing Total Knee Arthroplasy

NCT04203537 is registered in ClinicalTrials.gov with Concentric Analgesics as lead sponsor.

NCT NCT04203537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04203537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics and Preliminary Efficacy Study of CA-008 in Patients Undergoing Total Knee Arthroplasy
Lead sponsor
Concentric Analgesics
Phase
Phase 1/2
Overall status
Completed
Start date
December 4, 2019
Completion date
October 26, 2020
Enrollment
193 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

postsurgical pain